EUVIMEDEUVIMED entdecken
Crossref

Emapunil relieves osteoarthritis by regulating the CD14/TLR4/LY96 pathway in synovial macrophages through translocator protein 18 kDa

Jianbin Yin, Jialuo Huang, Junfeng Wu, Lingfeng Gao, Haoran Xu, Jinjian Zhu, Hanwen Mai, Jiaxin Luo, Zihao Yao, Yuexin Li, Haobin Li, Zhikun Yuan und 2 weitere

Osteoarthritis and Cartilage · 2025

DOI: 10.1016/j.joca.2025.06.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Osteoarthritis and Cartilage, 2025. Verfasst von Jianbin Yin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Surgery, Center for Orthopedic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China; De…. Hauptthemen laut MEDLINE: Macrophages, Osteoarthritis, Knee, Purines, Receptors, GABA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Excellent Young Scientists Fund, The Third Affiliated Hospital of Southern Medical University, Shijie Hospital of Dongguan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Osteoarthritis (OA), the most prevalent chronic degenerative joint disease, lacks effective therapies due to unclear pathogenesis. This study investigated the effects and mechanisms of translocator protein 18 kDa (TSPO) and its ligand emapunil in OA. METHODS: TSPO expression was assessed in synovium, macrophages, and cartilage from OA mice and patients. Macrophages TSPO was manipulated via plasmid and siRNA to evaluate polarization and inflammatory responses. Molecular docking was applied to evaluate TSPO affinity was validated by molecular docking, and its therapeutic effects were tested in vitro and in vivo. RNA sequencing analyzed Lipopolysaccharide (LPS)-induced M1 macrophages treated with Emapunil. RESULTS: TSPO was upregulated in OA synovium (particularly macrophages) but was unchanged in cartilage. Overexpression promoted M1 polarization and proinflammatory cytokine release, while TSPO inhibition showed no significant effects. Emapunil, a potent TSPO ligand, suppressed LPS-induced M1 polarization, reduced proinflammatory cytokines, and alleviated chondrocyte destruction. Intraperitoneal Emapunil attenuated synovitis and cartilage erosion in OA mice, lowering synovitis and Osteoarthritis Research Society International scores, reducing M1 macrophages and MMP13, while increasing COL2. Mechanistically, Emapunil downregulated CD14/LY96 mRNA via TSPO, inhibiting NF-κB/TLR signaling and M1 polarization. TSPO inhibition abolished Emapunil's regulatory effects on CD14/TLR4/LY96 pathways. CONCLUSION: TSPO plays an important role in OA occurrence and development. Emapunil targeting TSPO improves OA by modulating macrophage polarization and inflammation through the CD14/TLR4/LY96 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesOsteoarthritis, KneePurinesReceptors, GABASynovial MembraneSynovitisAgedAnimalsFemaleHumansMaleMiceMiddle AgedArthroplasty, Replacement, KneeCartilage, ArticularChondrocytesDisease Models, AnimalLigandsLipopolysaccharidesMice, Inbred C57BLMolecular Docking SimulationSignal TransductionUp-RegulationLipopolysaccharide ReceptorsToll-Like Receptor 4Lymphocyte Antigen 96

Stichwörter der Autor:innen

CD14/TLR4/LY96 pathwayEmapunilOsteoarthritisSynovial macrophagesTSPO

Substanzen

Bzrp protein, mouseLigandsLipopolysaccharidesN-benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl)acetamidePurinesReceptors, GABATSPO protein, humanLipopolysaccharide ReceptorsToll-Like Receptor 4Lymphocyte Antigen 96

Autor:innen und Institutionen

  • Department of Joint Surgery, Center for Orthopedic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China; Department of Orthopedics, Orthopedic Hospital of Guangdong Province, Ac…
  • Department of Orthopedics, Shijie Hospital of Dongguan City, Dongguan, China. Electronic address: yuanzhikun1213@163.com.

Förderung

  • Excellent Young Scientists Fund
  • The Third Affiliated Hospital of Southern Medical University
  • Shijie Hospital of Dongguan
  • National Key Research and Development Program of China

Zitieren

APA

Yin, J., Huang, J., Wu, J., Gao, L., Xu, H., Zhu, J., Mai, H., Luo, J., Yao, Z., Li, Y., Li, H., Yuan, Z., Cai, D., & Zhang, H. (2025). Emapunil relieves osteoarthritis by regulating the CD14/TLR4/LY96 pathway in synovial macrophages through translocator protein 18 kDa. Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2025.06.008

Vancouver

Yin J, Huang J, Wu J, Gao L, Xu H, Zhu J, et al. Emapunil relieves osteoarthritis by regulating the CD14/TLR4/LY96 pathway in synovial macrophages through translocator protein 18 kDa. Osteoarthritis and Cartilage. 2025. doi:10.1016/j.joca.2025.06.008

BibTeX
@article{Yin2025,
  author = {Yin, Jianbin and Huang, Jialuo and Wu, Junfeng and Gao, Lingfeng and Xu, Haoran and Zhu, Jinjian and Mai, Hanwen and Luo, Jiaxin and Yao, Zihao and Li, Yuexin and Li, Haobin and Yuan, Zhikun and Cai, Daozhang and Zhang, Haiyan},
  title = {Emapunil relieves osteoarthritis by regulating the CD14/TLR4/LY96 pathway in synovial macrophages through translocator protein 18 kDa},
  journal = {Osteoarthritis and Cartilage},
  year = {2025},
  doi = {10.1016/j.joca.2025.06.008}
}
Kostenlos starten →